Crinetics Pharmaceuticals Announces January 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 10, 2025 17:15 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 10, 2025 17:00 ET | Source: Xilio Therapeutics, Inc. WALTHAM, Mass.,…
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Craig Swandal, experienced medical device manufacturing executive, joins leadership team January 10,…
Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Carlsbad, CA, Jan. 03, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq:…
Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq
December 23, 2024 16:49 ET | Source: Neuphoria Therapeutics, Inc. BURLINGTON, Mass.,…
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
December 20, 2024 17:00 ET | Source: Iovance Biotherapeutics, Inc. SAN CARLOS,…
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 20, 2024 16:30 ET | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif.,…
AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
OCALA, Fla., Dec. 17, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE…
Cerence AI Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4)
BURLINGTON, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC)…
Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq
Jupiter, Florida, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (Nasdaq:…